The receptor for growth hormone-releasing hormone (GHRH-R) has been shown to upregulate specifically in the ciliary and iris epithelial cells and infiltrating cells in the aqueous humor in a rat model of acute anterior uveitis. Treatment with GHRHR-R antagonist alleviates significantly these inflammatory responses. Herein we investigated whether the ciliary and iris epithelial cells can respond directly to lipopolysaccharide (LPS) without the influences of circulating leukocytes to produce inflammatory mediators through a GHRH-R mediated mechanism. In explant cultures of rat ciliary body and iris, LPS caused a substantial increase of GHRH-R in 24 h. Immunohistochemistry showed a localization of TLR4, the receptor for LPS, and an elevated expression of IL-6 and IL-1β in ciliary and iris epithelial cells after LPS treatment. LPS also elevated the level of IL-1β, IL-6, and iNOS and increased secretion of IL-1β and IL-6 from the explants. The GHRH-R antagonist, MIA-602, suppressed the elevated expression of IL-1β and IL-6, and reduced the release of IL-6. Such effects were not seen for the GHRHR agonist, MR-409. When co-cultured with leukocytes, expression of GHRH-R in the ocular explants was further enhanced during LPS treatment. Our results demonstrate a direct action of LPS on ciliary and iris epithelial cells to produce pro-inflammatory factors through a GHRH-R mediated mechanism, and suggest a role of these epithelial cells, in addition to the resident antigen presenting cells, in immune surveillance of the eye. Infiltrating leukocytes may enhance these inflammatory responses by regulating GHRH-R in ciliary and iris epithelial cells, in addition to their functions of synthesizing proinflammatory cytokines.
Introduction
Uveitis is a group of diseases characterized by intraocular inflammation in the uveal tract, which includes iris, ciliary body and choroid, as well as in adjacent tissues such as retina, optic nerve and vitreous humor (Rothova et al., 1992) . Although immunosuppressive drugs such as corticosteroids and anti-metabolites are effective in clinical treatment, they cause serious side effects that include metabolic disorders, myasthenia and increased susceptibility to infection (Lee and Foster, 2010) . A safer and more effective treatment and prevention paradigm is needed.
Endotoxin-induced uveitis (EIU) induced by a systemic or intraocular administration of lipopolysaccharide (LPS) has been used an experimental model for infectious anterior uveitis (Forrester et al., 1980; Rosenbaum et al., 1980) . During this acute inflammatory process, a variety of cytokines such as interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemotactic protein-1 (MCP-1) are released, which trigger a breakdown of blood-ocular barrier and influx of leukocytes, macrophages and plasma proteins into the aqueous humor (Hoekzema et al., 1991; Koizumi et al., 2003; Tuaillon et al., 2002) . These inflammatory responses develop bilaterally in anterior segments of the eye (Suzuki et al., 2011) . It has been reported that the breakdown of blood-ocular barrier occurs 2 h after LPS injection and the inflammatory process reaches the peak in 18-24 h (Okumura and Mochizuki, 1988) . peptide that acts on somatotrophs in the anterior pituitary to stimulate their proliferation during development and regulate the secretion of growth hormone (GH) (Heaney and Melmed, 2004) . The GH then triggers the release of insulin-like growth factor-1 (IGF-1), largely from the liver, to affect anabolism and mitogenic function of neoplasms (Barabutis and Schally, 2010) . Apart from the endocrine control, GHRH also acts as an autocrine/paracrine growth factor in multiple human cancers, such as breast cancer and prostate cancer (Kiaris et al., 1999; Perez et al., 2012; Siriwardana et al., 2006) . Moreover, there is growing evidence that GHRH/GH/IGF-1 axis is involved in modulating immune functions. For example GHRH-R deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis (EAE) (Ikushima et al., 2003) , and GH treatment restores the original susceptibility to EAE (Shohreh et al., 2011) . GHRH, GH and IGF-1 also augment differentiation of granulocytes into mature immune cells that produce cytokines and synthesize GH and IGF-1 (Kelley, 1990; Kiaris et al., 1999; Saito et al., 1996) . Our earlier study showed that LPS triggers an acute increase in expression of pro-inflammatory factors in anterior segments of the eye in adult rats, which are repressed by GHRH-R antagonists (Qin et al., 2014) . However, it remains unclear how these antagonists exert antiinflammatory actions. GHRH-R is localized specifically on the epithelial cells of ciliary body and iris, and its expression is elevated after a footpad injection of LPS, suggesting that these epithelial cells are primary targets of the antagonist (Qin et al., 2014) . However, GHRH-R is also expressed on infiltrating inflammatory cells, which accumulate in the aqueous humor as a result of breakdown of the blood-ocular barrier. In current study we sought to investigate: i) whether epithelial cells of ciliary body and iris, in the absence of circulating leukocytes, are able to respond directly to LPS and produce proinflammatory mediators; ii) whether this inflammatory process is suppressed by inhibiting GHRH-R activity.
Materials and methods

Animals
All the animal experiments were carried out in accordance to the guidelines of Association for Research in Vision and Ophthalmology (ARVO) Statement on Use of Animals in Ophthalmic and Vision Research. The study was approved by the Animal Experimentation Ethics Committee of The Chinese University of Hong Kong. Male Sprague-Dawley rats, weighted 230-250g, were obtained from the Laboratory Animal Service Center of The Chinese University of Hong Kong. The animals were housed in a room with 12/12 h light/dark cycles, with free access to food and water.
Preparation of iris and ciliary body explants
The rats were anesthetized by an intraperitoneal injection of 0.4 ml of ketamine hydrochloride-xylazine mixture (1.5:1, Alfasan International B.V., Holland), and perfused transcardially with 150 ml of sterile saline to remove the peripheral blood. The eyeballs were dissected out and maintained in ice-chilled Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEA-F12) medium supplemented with 1% Penicillin-Streptomycin (PS). Iris and ciliary body were isolated under microscope and cultured on a membrane with pore diameter of 0.4 μm in a transwell culture plate. Rosewell Park Memorial Institute 1640 (RPMI 1640) medium (1 ml) supplemented with 10% fetal bovine serum (FBS) and 1% PS was added to the lower chamber of the transwell to provide nutrients to the explants. All drugs were added into the lower chamber and the culture was incubated for 24 h (Fig. 1A) .
Isolation and characterization of peripheral blood leukocytes
The rats were anesthetized by intraperitoneal injection of 0.4 ml of ketamine hydrochloride-xylazine mixture (1.5:1). Peripheral blood was collected by cardiac puncture and 1.5x volume of 2% dextran solution (Cat. No. 31392, Sigma; in saline) was added immediately. After sedimentation of dextran in around 20 min, the upper layer containing the leukocytes-rich fraction was centrifuged at 100g (690 rpm) for 10 min at room temperature. The pellet was suspended in 15 ml 0.2% hypotonic NaCl solution, gently mixed for 30 s, and then 15 ml 1.6% hypertonic solution was added to lyse the red blood cells. After centrifugation at 100g for another 10 min, cells were washed three times with 10 ml phosphate buffered saline (PBS) and finally re-suspended in 1 ml RPMI 1640 medium supplemented with 10% FBS and 1% antibiotics (penicillin, streptomycin and neomycin) in 5% CO 2 at 37°C in humidified incubator. 1 × 10 6 leukocytes were suspended in 1 ml PBS containing 0.25 μg/ml fluorescein isothiocyanate (FITC) or phycoerythrin (PE)-coupled antibodies against CD11b and CD3. Cells were washed three times with 1 ml of PBS and re-suspended in 1 ml of PBS. Fluorescence signals were evaluated by flow cytometry in a FACS Calibur instrument and the data were analyzed by CellQuest software.
Co-culture of iris-ciliary body and leukocytes
Isolated leukocytes at different concentrations were re-suspended in 1 ml of RPMI 1640 medium supplemented with 10% FBS and 1% antibiotics. The cells were seeded into the lower chamber of a transwell, and cultured together with the ciliary body and iris explant in the upper chamber for 24 h. LPS was added into lower chamber to a final concentration of 100 ng/ml at the start of the experiment. Control preparations were treated with same volume of PBS.
Quantification of GHRH-R expression by Western blot
The expression of GHRH-R was analyzed in iris and ciliary body explants after culturing alone or in the presence of leucocytes in the lower chamber of a transwell for 24 h. LPS (to a final concentration of 100 ng/ml) or same volume of saline (in controls) was added into the lower chamber at the beginning of the experiment. The explants were harvested and homogenized in 1x RIPA lysis buffer (Millipore, USA) with a protease inhibitor cocktail (Roche, Switzerland) at the ratio of 6:1. The protein homogenization was centrifuged at 12,000 rpm at 4°C for 30 min and the supernatant containing protein was collected. The concentration of protein was determined with Braford protein assay. A total of 25 μg protein was loaded and resolved using 12% SDS polyacrylamide gel. GHRH-R antibody (Cat No. ab28692, Abcam) was used as primary antibody to detect the protein in the ocular tissues. The target bands were visualized with enhanced chemiluminescence and the band intensity was analyzed with Gene Tools from Syngene software after normalization with the housekeeping protein revealed by the β-actin antibody (Cat No. ab8226, Abcam).
Immunohistochemistry
The ciliary body and iris explants were fixed with 4% paraformaldehyde overnight at 4°C. The tissues were embedded in optimal cutting temperature compound (OCT) and frozen sections in 7 μm thickness were collected using a cryostat. After washing with PBS, the sections were blocked with 10% normal goat serum, and then incubated in primary antibody against GHRH-R, TLR4, IL-6 or IL-1β overnight at 4°C. On the following day, the sections were washed with PBS and incubated in secondary antibody for 1 h at room temperature. The sections were washed with PBS and mounted on glass slides. Fluorescence signals were visualized with the Olympus Confocal Microscope (FV300, Olympus Co, Japan). Control sections were treated with the same procedure but with the absence of primary antibody. No obvious signal was observed in these control preparations.
Induction of EIU in adult rats
Acute uveitis was induced in adult rats by injection of lipopolysaccharide (LPS) (Sigma-Aldrich, USA; in 0.1 ml volume) at the dose of 1 mg/kg into one footpad (Qin et al., 2014) . Control animals received unilateral injection of 0.1 ml sterile saline. After 24 h, the rats were anesthetized by ketamine-xylazine mixture, perfused with 0.01M PBS and 4% paraformaldehyde. The eyes were dissected and further fixed in 10% formalin overnight. The tissues were embedded in paraffin and sectioned at 5 μm thickness. The sections were processed for immunohistochemistry to detect expression of IL-1β and IL-6 in the ciliary body and iris.
GHRH-R peptides
GHRHR antagonist, MIA-602, and GHRHR agonist, MR-409, were prepared by the laboratory of Prof. Andrew Schally. The chemical structure of MIA-602 is [PhAc-Ada0, D-Arg2, Fpa56, Ala8, Har9, Tyr (Me)10, His11, Orn12, Abu15, His20, Orn21, Nle27, D-Arg28, Har29] hGH-RH(1-29)NH2. The structure of MR-409 is [N-Me-Tyr1, D-Ala2, Orn12, Abu15, Orn21, Nle27, Asp28] hGH-RH (1-29) NH-CH3. Both chemicals were dissolved in 100% dimethyl sulfoxide (DMSO, ACS grade, Sigma) for stock, and diluted at 1:1000 in corresponding culture medium to a final concentration of 1 μM before use. Control group was treated with the medium containing same concentration of DMSO.
Real-time PCR
MIA-602 or MR-409 was added into the culture medium at the lower chamber of a transwell well 1 h before the administration of LPS (final concentration at 100 ng/ml). After 24 h, the ciliary body and iris explants were lysed with reagents from the RNA Extraction kit (FATRK001, Favorgen Biotech Corp). The mRNAs were converted into cDNA according to a standard reverse-transcription protocol (Applied Biosystems, USA). Quantitative real time PCR was performed with SYBR green mixture, comprising 5 μl of 2X SYBR green master mix (Applied Biosystems, USA), 4 μl of cDNA, 0.5 μl of 10 nM forward primer, and 0.5 μl of 10 nM reverse primer (Invitrogen, USA). The primers used in this study were listed below: IL-1β, forward: 5′-CTTT CATCACACAGGACAGG-3′, reverse 5′-GTGATGTTCCCATTAGACAGC-3'; IL-6, forward: 5′-GACTGATGTTGTTGACAGCCACTGC-3′, reverse 5′-TAGCCACTCCTTCT-GTGACTCTAACT-3'; iNOS, forward: 5′-CGTGT GCCTGCTGCCTTTGCTGT-3′, reverse 5′-GTAATCCTCAACCTGCTCCTC ACTC-3'. The program applied was as follows: 95°C pre-incubation for 10 min, 95°C denaturation for 15 s (40 cycles), and 60°C annealing for 1 min. The CT value was determined by ABI Quantstudio Flex Real Time PCR machine and normalized to β-actin gene with the ΔΔCT calculation method.
2.10. Detection of secreted IL-1β, IL-6, and IGF-1 by Enzyme-Linked Immunosorbent Assay (ELISA)
The Rat IL-1β, IL-6, and IGF-1ELISA kits were purchased from R&D Systems (MG100, RLB00, and R6000B, respectively). ELISA was conducted following the manufacturer's instructions to monitor the amount of IL-1β, IL-6, and IGF-1 secreted by the iris and ciliary body explants.
Data processing and analysis
All data were presented as mean ± SEM and comparisons were made by using Mann-Whitney tests or Kruskal Wallis tests of the SPSS 16.0 software. The differences were considered statistically significant when the p value was less than 0.05. Fig. 1 . LPS stimulates the expression of GHRH-R in explant cultures of iris and ciliary body. (A) Adult rats were perfused with saline and irisciliary body was dissected and cultured on the membrane in a transwell. LPS and other chemicals were added to the lower chamber. (B, C) Western blot results showed that GHRH-R protein level was increased significantly after LPS treatment when compared with the controls (n = 8). (D) RT-PCR confirmed the expression of GHRH-R was elevated by LPS treatment (n = 5). (E, F) Immunohistochemistry showed the localization of GHRH-R in the ciliary and iris epithelium, which is stronger in staining in LPS treated explants. *: p < 0.05; **: p < 0.005.
Results
LPS increased GHRH-R expression in explant culture of iris and ciliary
To investigate whether the ciliary body and iris respond directly to LPS and upregulate expression of GHRH-R, the ocular tissues were isolated from adult rats after perfusion with saline to remove blood cells from the vessels in these tissues. The explants were cultured on a membrane in a transwell preparation that allows nutrient supply from the lower chamber (Fig. 1A) . Western blot analysis showed that GHRH-R was elevated significantly in the ocular explants 24 h after addition of LPS (p < 0.01) (Fig. 1B-C) . This increase was confirmed in RT-PCR analysis showing LPS treatment stimulated significant increase in expression of GHRH-R mRNA in these tissues (p < 0.05) (Fig. 1D) . Further support was obtained from immunohistochemistry, showing localization of GHRH-R in the epithelial cells of ciliary body and iris (Fig. 1E) , and an elevated expression in these cells after LPS treatment (Fig. 1F) .
Release of pro-inflammatory mediators from the ciliary body and iris explants
To test whether the ciliary body and iris are able to produce and secrete pro-inflammatory mediators without the influence of circulating leukocytes, expression and secretion of these factors were determined in explant cultures of these ocular tissues 24 h after LPS treatment ( Fig. 2A) . RT-PCR analysis showed a dramatic increase in expression of IL-1β, IL-6, and iNOS genes in the explants, when compared with the control that received equal volume of PBS (p < 0.01) (Fig. 2B) . The release of pro-inflammatory cytokines was detected in the medium in the lower chamber of the culture well. ELISA showed that there was a basal release of IL-1β and IL-6 from control cultures of ciliary body and iris. LPS treatment stimulated significant increase in the levels of IL-1β and IL-6 by 16.71 fold (p < 0.05) and 4.98 fold (p < 0.01), respectively ( Fig. 2C-D ). These findings demonstrate the ability of ciliary body and iris in synthesizing and secreting pro-inflammatory factors upon stimulation of LPS.
Localization of TLR4 and inflammatory cytokines in the ciliary body and iris
To further investigate the ability of ciliary body and iris in production of cytokines in response to LPS, we examined the localization of the receptor for LPS, toll-like receptor 4 (TLR4), and the cytokines IL-6 and IL-1β in explant culture of ocular tissues using immunohistochemistry. In control tissues, TLR4 was localized on the epithelial cells in the ciliary body and iris, and the stroma of iris (Fig. 3A and C) . Treatment of LPS appeared to increase the expression in these tissues, particularly in the stroma of the iris (Fig. 3B and D) . Staining for IL-6 and IL-1β in control preparations revealed a sporadic expression in ciliary epithelial cells (Fig. 3E and I) , whereas considerable amount of expression was observed in the posterior epithelium and stroma of the iris (Fig. 3G and K) . Upon stimulation of LPS, there was an obvious increase in staining for IL-6 and IL-1β in ciliary epithelial cells (Fig. 3F and J) . While the staining in the stroma of iris remained prominent after LPS treatment, there was a depletion of staining from the posterior epithelium ( Fig. 3H and L) . The presence of TLR4 supports the ability of ciliary and iris epithelial cells to respond to LPS by producing proinflammatory cytokines such as IL-6 and IL-1β.
To confirm the ability of ciliary and iris epithelial cells in production of pro-inflammatory cytokines, expression of IL-6 and IL-1β was determined in paraffin sections of the eyes in adult rats 24 h after LPS injection. In control animals, which received injection of saline into one footpad, there was no obvious staining for both cytokines in the epithelium of ciliary body ( Fig. 4A and E) and iris ( Fig. 4C and G) . A footpad injection of LPS triggered increases in staining for IL-6 and IL-1β in ciliary epithelial cells, as well as in inflammatory cells in the aqueous humor ( Fig. 4B and F) . In the iris, the increases were detected largely in the macrophage-like cells in the stroma (Fig. 4D and H) , and in a few epithelial cells at the posterior epithelium. These findings add further support to the ability of ciliary and iris epithelial cells, together with the resident antigen presenting cells, in the production of pro- Fig. 2 . Production of pro-inflammatory factors from the ciliary body and iris. (A) Iris and ciliary body explants were cultured on the transwell. (B) LPS treatment caused an increase in expression of IL-1β, IL-6 and iNOS genes in the explant tissues (n = 5). (C-D) ELISA results showed that there was dramatic increase in secretion of IL-1β and IL-6 from the explants into the medium at the lower chamber after LPS treatment. *: p < 0.05; **: p < 0.005. inflammatory cytokines in response to stimulation of LPS.
GHRH-R activity regulated inflammatory responses in ciliary body and iris explants
To explore the role of GHRH-R in this inflammatory process, the ciliary body and iris explants were pretreated with either 1 μM MIA-602, a GHRH-R antagonist, or 1 μM MR-409, a GHRH-R agonist, 1 h before exposure to LPS. RT-PCR analysis showed that the elevated expression of IL-1β, IL-6 and iNOS induced by LPS was all suppressed significantly by MIA-602 24 h after LPS treatment (p < 0.05, p < 0.01, p < 0.05) (Fig. 5A-C) . The agonist MR-409 did not reduce the responses, and significant increase was observed for IL-6 (p < 0.05). ELISA analysis indicated that treatment of the GHRH-R antagonist ameliorated significantly the LPS-induced increase in release of IL-6 from the explants (p < 0.05) (Fig. 5D ). Such effect was not observed after treatment with the agonist, indicating that the production and release of pro-inflammatory factors in ciliary body and iris explants were mediated by GHRH-R activity.
To further investigate the anti-inflammatory actions of the antagonist, explant cultures were treated with MIA-602 at the dose of 1 μM or 5 μM. RT-PCR results showed that MIA-602 caused a dose dependent reduction in expression of IL-1β 24 h after LPS treatment (Fig. 6A) . Similar trend of changes was observed for IL-6, in which the cytokine expression was reduced significantly after treatment with 1 μM MIA-602 (p < 0.01, Kruskal Wallis ANOVA Test), when compared with LPS (Fig. 6B ). IL-6 expression was further reduced with 5 μM treatment (p < 0.005, compared with LPS), though this effect was not statistically different from that of 1 μM. The dose dependent changes were not observed for iNOS, in which significant reduction was found only with treatment of 1 μM MIA-602 (p < 0.05, compared with LPS), but not with 5 μM treatment (Fig. 6C) .
Regulation of GHRHR expression in ciliary body and iris by leukocytes
One characteristic of anterior uveitis is the accumulation of inflammatory cells in the aqueous humor, arising from the breakdown of the blood-ocular barrier. The role of these blood derived leukocytes on the expression of GHRH-R in the ciliary body and iris was investigated in a transwell culture, in which the ciliary body and iris explants were cultured on the membrane filter with leukocytes (1 × 10 6 in 1 ml medium) seeded in the lower chamber (Fig. 7A ). Leukocytes were partially purified from rat whole blood using centrifugation. Flow cytometry analysis showed that in these preparations 58.76% of the cells were CD11b positive monocytes, macrophages and granulocytes, whilst 25.36% were CD3 positive T-lymphocytes (Fig. 7B) . The gene expression of IL-1β, IL-6 and iNOS in the explants were upregulated dramatically 24 h after LPS treatment (p < 0.05, p < 0.05, p < 0.05) (Fig. 7C) , which was 3-4 fold higher than the corresponding levels in explants cultured alone (Fig. 2B) , suggesting that the presence of leukocytes enhanced the inflammatory responses in the iris and ciliary body. Western blot analysis showed that this enhanced production of inflammatory mediators was associated with an elevation expression of GHRH-R in the explant, and that this increase was dependent on the amount of leukocytes in the lower chamber (Fig. 7D) . To verify whether IGF-1 was involved in this inflammatory process, IGF-1 in the culture medium was measured using ELISA. The results showed a significant reduction in IGF-1 24 h after LPS treatment in co-cultures of explants and leukocytes (p < 0.05) (Fig. 7E) . The reduction was less in cultures with explant alone, and was not detectable in leukocyte culture, Fig. 5 . GHRH-R antagonist reduces the expression and release of proinflammatory factors from the ciliary body and iris explants. The GHRH-R antagonist, MIA-602, or agonist, MR-409, both at 1 μM, was added into the lower chamber of the transwell culture. (A-C) MIA-602 suppressed partly the elevated expression IL-1β, IL-6 and iNOS genes in the ocular tissues 24 h after LPS treatment. Treatment with MR-409 tended to increase expression of these genes (n = 10). (D) ELISA showed the release of IL-6 from the explants was decreased by MIA-602 but not by MR-409 (n = 4). *: p < 0.05; **: p < 0.005; n.s.: no significant difference. indicating the ocular inflammation is not associated with the activation of the classical GHRH-R/GH/IGF-1 signaling axis.
Discussion
In the present study, we investigated the role of GHRH-R in ocular inflammation induced by LPS in explant cultures of rat ciliary body and iris. The major findings include: i) the ciliary body and iris are able to synthesize and release pro-inflammatory cytokines in response to LPS in the absence of influences from circulating leukocytes; ii) these inflammatory responses are associated with an increase in GHRH-R expression in the epithelial cells of ciliary body and iris; iii) TLR4 is expressed constitutively on the epithelium of ciliary body and iris; iv) GHRH-R antagonist produces a partial suppression to the expression and release of pro-inflammatory mediators from the explants; v) the presence of leukocytes enhances expression of inflammatory mediators in the ocular explants, and these increases are associated with an increase in GHRH-R expression in the ciliary and iris epithelium. These findings support strongly that the ciliary and iris epithelial cells play an important role in ocular inflammation through the GHRH-R, and that the circulating leukocytes regulate these inflammatory responses by modulating the expression of GHRH-R in the ciliary and iris epithelial cells.
Our earlier study has shown that LPS induced acute anterior uveitis in adult rats, which was accompanied by an increased level of expression of GHRHR in the ciliary and iris epithelial cells (Qin et al., 2014) . Using an explant culture preparation, we confirm that iris and ciliary body alone can respond directly to LPS by producing and secreting proinflammatory factors such as IL-1β, IL-6 and iNOS, in the absence of circulating immune cells. The production of cytokines relies largely on the epithelial cells of ciliary body and iris, as these cells are the major cell types expressing TLR4 in the explant. The current results also show an obvious increase in pro-inflammatory cytokines IL-1β and IL-6 within the ciliary epithelial cells after LPS treatment, supporting strongly that these cells are the sources of cytokines in the aqueous humor at the initial stage of ocular inflammation. The ability of the ciliary and iris epithelial cells in cytokine production is further shown in animals after LPS treatment, in which the levels of IL-6 and IL-1β are elevated in the epithelial cells, particularly in the ciliary epithelium. However, it is noted that the presence of cytokines in the stroma of iris, as observed in the control explants, is not detected in the iris of control animals, suggesting that the cytokine production is probably caused by the experimental manipulations or a change in external environment during the culture of explants. The current ex vivo model cannot fully mimic the physiology conditions in the eye, such as the immunosuppressive milieu of the aqueous humor. The depletion of cytokines from the iris epithelial cells as revealed in the explants may represent an active release during the inflammatory process, which may gain support from the in vivo findings that only a small amount of IL-1β and IL-6 is localized in the iris epithelium after LPS treatment. Previous reports have shown a constitutive expression of TLR4 in human ciliary and iris epithelial cells (Brito et al., 2004; Chui et al., 2010) . Moreover, LPS is able to stimulate production of an array of pro-inflammatory cytokines from primary human iris pigment epithelium (Chui et al., 2010) , whereas primary rabbit pigmented ciliary epithelial cells have been shown to produce IL-6 upon stimulation of IL-1β (Fleisher et al., 2000) , indicating the ability of these ocular cells in production of proinflammatory cytokines. These findings together indicate that ciliary and iris epithelial cells are contributing to immune surveillance in the eye, acting together with antigen presenting cells resident in these tissues as the first line defense against pathogenic substances.
We show further that this inflammatory process is mediated by GHRH-R activity in the body ciliary and iris, confirming our earlier findings in in vivo studies (Qin et al., 2014) . The GHRH-R antagonist, MIA-602, acts directly on the GHRH-R and alleviates the elevation of IL-1β, IL-6 and iNOS; whilst the agonist, MR-409, tends to enhance expression of these genes. These anti-inflammatory effects are largely contributed by the epithelial cells, as they are the major cell types expressing GHRH-R during the LPS treatment in these ocular tissues. Moreover, in rats with EIU, GHRH-R is localized on the macrophages and leukocytes in the aqueous humor, but not on these immune cells within the stroma of the iris (Qin et al., 2014) , suggesting that these resident immune cells are contributing minimally, if any, to these antiinflammatory actions. The results in the current study are consistent with findings in previous reports showing a potent anti-inflammatory action of GHRH-R antagonist in benign prostatic hyperplasia and acute The expression of GHRH-R in ocular explants was correlated positively to the amount of leukocytes (n = 3). (E) ELISA showed that the concentration of IGF-1, the downstream effector of GHRH signaling axis, was reduced after LPS treatment. *p < 0.05; **p < 0.005; n.s.: no significant difference.
anterior uveitis in rats (Qin et al., 2014; Rick et al., 2011) . It should be noted that expression of IGF-1 is reduced in iris and ciliary body explants, and the level of secreted IGF-1 in the medium is reduced after LPS treatment. These results indicate that the GHRH-R mediated production of cytokines is not regulated through the classic GHRH/GH/ IGF-1 axis, but likely by other signaling cascades that mediate production of inflammatory factors.
Another major finding in the current study is that the GHRH-R in ciliary body and iris are regulated by the blood-derived leukocytes. LPS has been shown to drive the binding of circulating leukocytes to vascular epithelial cells, leading eventually to diapedesis of leukocytes from the blood vessels into the tissue (Aplin et al., 1998) . In acute uveitis, the cytokines released from the ciliary and iris epithelial cells likely cause a breakdown of blood-ocular barrier, resulting in influx of proteins and inflammatory leukocytes into the aqueous humor. Report from an earlier study has shown that the leukocytes can interact with ciliary body and inhibit proliferation of T lymphocytes (Helbig et al., 1990) . In addition to this interaction, we show further that the leukocytes, upon stimulation by LPS, can actually upregulate the expression of GHRH-R in explant culture of ciliary body and iris. This interaction is likely mediated by diffusible factors produced by the leukocytes, which exacerbates the inflammatory response in anterior segments of the eye through stimulation of production of proinflammatory factors in the ciliary and iris epithelial cells.
In conclusion, we have provided evidences that ciliary and iris epithelial cells are able to respond to LPS and produce proinflammatory factors, playing a role similar to the antigen presentation cells to recruit leukocytes into the aqueous humor. The entry of leukocytes further exaggerates the inflammatory responses, partly by their abilities in releasing proinflammatory cytokines, and partly by upregulating expression of GHRH-R in the ciliary and iris epithelial cells. 
